Sysmex (OTCMKTS:SSMXY) Trading Up 5.9% – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY) shares rose 5.9% during mid-day trading on Monday . The company traded as high as $9.82 and last traded at $9.82. Approximately 5,246 shares were traded during trading, a decline of 97% from the average daily volume of 155,414 shares. The stock had previously closed at $9.27.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group upgraded shares of Sysmex from a “hold” rating to a “buy” rating in a report on Thursday, October 9th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Sysmex Stock Up 4.6%

The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.49 and a current ratio of 3.34. The company has a fifty day simple moving average of $10.69 and a two-hundred day simple moving average of $13.50. The firm has a market capitalization of $6.11 billion, a PE ratio of 19.40 and a beta of 1.17.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Sysmex had a return on equity of 9.86% and a net margin of 9.32%.The firm had revenue of $826.60 million for the quarter, compared to analyst estimates of $880.80 million. Analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.